Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 61 - 68 of 68 items for :

Clear All
Christine Rode Andreasen Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Christine Rode Andreasen in
Google Scholar
PubMed Close
,
Andreas Andersen Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Andreas Andersen in
Google Scholar
PubMed Close
,
Filip Krag Knop Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Filip Krag Knop in
Google Scholar
PubMed Close
, and
Tina Vilsbøll Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed Close

tested in the other CVOTs ( Table 1 ), the short follow-up period of 2 years and the highest percentage of participants on statin therapy ( Table 2 ). The EXSCEL trial did not find any significant difference in the primary outcome between treatment with

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0130
Volume/Issue:
Volume 10: Issue 7
Open access
J Brossaud Université de Bordeaux, Nutrition et Neurobiologie Intégrée, Bordeaux, France
Department of Nuclear Medicine, CHU de Bordeaux, Pessac, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France

Search for other papers by J Brossaud in
Google Scholar
PubMed Close
,
V Pallet Université de Bordeaux, Nutrition et Neurobiologie Intégrée, Bordeaux, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France

Search for other papers by V Pallet in
Google Scholar
PubMed Close
, and
J-B Corcuff Université de Bordeaux, Nutrition et Neurobiologie Intégrée, Bordeaux, France
Department of Nuclear Medicine, CHU de Bordeaux, Pessac, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France

Search for other papers by J-B Corcuff in
Google Scholar
PubMed Close

adipocytes . Journal of Nutrition 2008 138 1004 – 1009 . 10.1093/jn/138.6.1004 95 Iacobazzi V Convertini P Infantino V Scarcia P Todisco S Palmieri F. Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-17-0101
Volume/Issue:
Volume 6: Issue 7
Open access
Eva O Melin Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden
Department of Research and Development, Växjö, Sweden
Primary Care, Växjö, Sweden

Search for other papers by Eva O Melin in
Google Scholar
PubMed Close
,
Jonatan Dereke Department of Clinical Sciences Lund, Diabetes Research Laboratory, Lund University, Lund, Sweden

Search for other papers by Jonatan Dereke in
Google Scholar
PubMed Close
,
Maria Thunander Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden
Department of Research and Development, Växjö, Sweden
Department of Internal Medicine, Endocrinology and Diabetes, Central Hospital, Växjö, Sweden

Search for other papers by Maria Thunander in
Google Scholar
PubMed Close
, and
Magnus Hillman Department of Clinical Sciences Lund, Diabetes Research Laboratory, Lund University, Lund, Sweden

Search for other papers by Magnus Hillman in
Google Scholar
PubMed Close

and insulin resistance. Lipid-lowering drugs (LLD) were hydroxy-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins) (C10AA). Indications for LLD were TC >4.5 mmol/L (>1.74 mg/dL) and/or LDL >2.5 mmol/L (>97 mg/dL) according to local

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0336
Volume/Issue:
Volume 7: Issue 12
Open access
Espen Nordheim Department of Transplantation Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Faculty of Medicine, University of Oslo, Oslo, Norway

Search for other papers by Espen Nordheim in
Google Scholar
PubMed Close
and
Trond Geir Jenssen Department of Transplantation Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Faculty of Medicine, University of Oslo, Oslo, Norway
Metabolic and Renal Research Group, Faculty of Health Sciences, UiT- The Arctic University of Norway, Tromsø

Search for other papers by Trond Geir Jenssen in
Google Scholar
PubMed Close

diabetes A comprehensive care is recommended for the management of diabetes patients in the recent KDIGO clinical practice guidelines ( 21 ), including statins to all patients with diabetes and kidney disease regardless of cholesterol levels to prevent

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0097
Volume/Issue:
Volume 10: Issue 5
Open access
Jan Kvasnička 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Jan Kvasnička in
Google Scholar
PubMed Close
,
Ondřej Petrák 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Ondřej Petrák in
Google Scholar
PubMed Close
,
Tomáš Zelinka 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Tomáš Zelinka in
Google Scholar
PubMed Close
,
Judita Klímová 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Judita Klímová in
Google Scholar
PubMed Close
,
Barbora Kološová 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Barbora Kološová in
Google Scholar
PubMed Close
,
Květoslav Novák Department of Urology, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Květoslav Novák in
Google Scholar
PubMed Close
,
David Michalský 1st Department of Surgery, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by David Michalský in
Google Scholar
PubMed Close
,
Jiří Widimský Jr 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Jiří Widimský Jr in
Google Scholar
PubMed Close
, and
Robert Holaj 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Robert Holaj in
Google Scholar
PubMed Close

Angiotensin receptor blockers ( n (%)) 4 (17) 1 (4) NS α-blockers ( n (%)) 8 (33) 0 (0) <0.005 Central agonists ( n (%)) 2 (8) 0 (0) NS Aldosterone antagonists ( n (%)) 1 (4) 0 (0) NS Statins ( n (%)) 8

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0462
Volume/Issue:
Volume 10: Issue 12
Open access
Christian Trummer Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Christian Trummer in
Google Scholar
PubMed Close
,
Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Stefan Pilz in
Google Scholar
PubMed Close
,
Verena Schwetz Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Verena Schwetz in
Google Scholar
PubMed Close
,
Barbara Obermayer-Pietsch Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Barbara Obermayer-Pietsch in
Google Scholar
PubMed Close
, and
Elisabeth Lerchbaum Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Elisabeth Lerchbaum in
Google Scholar
PubMed Close

cardiovascular risk 62 ± 11 years OR 2.47 (1.55–3.93) for men with 25(OH)D <25 nmol/L compared to >75 nmol/L ↑TT, ↑FAI ↓SHBG Age, BMI, wine consumption, smoking, beta-blocker use, statin use and diabetes Heijboer et al . ( 86 ) 183 men (101 men

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0009
Volume/Issue:
Volume 7: Issue 3
Open access
Qian Deng Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Qian Deng in
Google Scholar
PubMed Close
,
Yue Zhu Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Yue Zhu in
Google Scholar
PubMed Close
,
Mengmeng Zhang Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Mengmeng Zhang in
Google Scholar
PubMed Close
,
Aihua Fei Department of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Aihua Fei in
Google Scholar
PubMed Close
,
Jiaqi Liang Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Jiaqi Liang in
Google Scholar
PubMed Close
,
Jinjin Zheng Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Jinjin Zheng in
Google Scholar
PubMed Close
,
Qingping Zhang College of Acupuncture-moxibustion and Tuina, Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Qingping Zhang in
Google Scholar
PubMed Close
,
Tong Cheng Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Tong Cheng in
Google Scholar
PubMed Close
, and
Xia Ge Department of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Xia Ge in
Google Scholar
PubMed Close

statins and fibrates in the management of cardiovascular risk . Current Opinion in Lipidology 2009 20 505– 511 . ( https://doi.org/10.1097/MOL.0b013e328332e9ef ) 105 Xu N Wang Q Jiang S Wang Q Hu W Zhou S Zhao L Xie L Chen J Wellstein

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0419
Volume/Issue:
Volume 12: Issue 3
Open access
E T Aristizabal Prada Department of Internal Medicine IV, Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by E T Aristizabal Prada in
Google Scholar
PubMed Close
and
C J Auernhammer Department of Internal Medicine IV, Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by C J Auernhammer in
Google Scholar
PubMed Close

well as several other drugs like phenformin, resveratrol, berberine, statins, epigallocatechin gallate and capsaicin, have been suggested to exert anti-tumoural effects by activation of AMPK and inhibition of mTOR ( 93 ). In the human NET cell lines

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-17-0286
Volume/Issue:
Volume 7: Issue 1
Open access